Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid TT Electronics (TTG) by Steve Moore in ShareProphets
- Avoid Solid State (SOLI) by Steve Moore in ShareProphets
- Sell Victoria (VCP) by Tom Winnifrith in ShareProphets
- Hold Burberry Group (BRBY) by Stifel
- Neutral Hammerson (HMSO) by UBS
- Buy XPS Pensions Group (XPS) by Deutsche Bank
- Buy Direct Line Insurance Group (DLG) by Deutsche Bank
- Hold Aviva (AV.) by Deutsche Bank
- Buy Cerillion (CER) by Berenberg
- Buy Judges Scientific (JDG) by Jefferies
- Hold Drax Group (DRX) by HSBC
- Hold Robert Walters (RWA) by HSBC
- Overweight United Utilities Group (UU.) by Morgan Stanley
- Buy SThree (STEM) by HSBC
- Buy Hays (HAS) by HSBC
- Hold TT Electronics (TTG) by Berenberg
- Outperform WH Smith (SMWH) by RBC Capital
- Sector Perform 3i Group (III) by RBC Capital
- Outperform B&M European Value Retail S.A. (DI) (BME) by RBC Capital
- Outperform XPS Pensions Group (XPS) by RBC Capital
Synairgen (SNG) Share Price
Health Care Sector
NOTE: This is based on 29 open tips for Synairgen (SNG)
| Latest Bid : 4.65p | Latest Ask : 4.92p |
| High Today : 4.92p | Low Today : 4.55p |
| This Years High : 9.80p | This Years Low : 3.40p |
| Volume : 132,746 | MKT Cap : £9.74M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Synairgen (SNG) Overview
In the 1970s, Synairgen founder, British immunophysician Professor Sir Stephen Holgate, began investigating how respiratory viruses can cause serious illness, with the aim of translating these insights into effective clinical treatments. Joined by fellow University of Southampton professors Donna Davies and Ratko Djukanovic in the 1990s, together the three formed Synairgen in 2003 with the sole aim of bringing these advances to patients.Synairgen (SNG) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Deutsche Bank | Premium Only | 2024-05-07 06:48:00 07/05/2024 | -22.26% |
| Hold | Richard Evans | Premium Only | 2021-11-10 07:45:00 10/11/2021 | -97.43% |
| Speculative Buy | Rupert Hargreaves | Premium Only | 2021-10-20 11:20:00 20/10/2021 | -97.12% |
| Speculative Buy | Rupert Hargreaves | Premium Only | 2021-06-16 14:25:00 16/06/2021 | -96.55% |
| Watch | Richard Evans | Premium Only | 2021-06-02 08:25:00 02/06/2021 | – |
Synairgen (SNG) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 4.65p | Latest Ask : 4.92p |
| High Today : 4.92p | Low Today : 4.55p |
| This Years High : 9.80p | This Years Low : 3.40p |
| Volume : 132,746 | MKT Cap : £9.74M |
Synairgen Overview
In the 1970s, Synairgen founder, British immunophysician Professor Sir Stephen Holgate, began investigating how respiratory viruses can cause serious illness, with the aim of translating these insights into effective clinical treatments. Joined by fellow University of Southampton professors Donna Davies and Ratko Djukanovic in the 1990s, together the three formed Synairgen in 2003 with the sole aim of bringing these advances to patients.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Synairgen Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Deutsche Bank | Premium Only | 2024-05-07 06:48:00 07/05/2024 | -22.26% |
| Hold | Richard Evans | Premium Only | 2021-11-10 07:45:00 10/11/2021 | -97.43% |
| Speculative Buy | Rupert Hargreaves | Premium Only | 2021-10-20 11:20:00 20/10/2021 | -97.12% |
| Speculative Buy | Rupert Hargreaves | Premium Only | 2021-06-16 14:25:00 16/06/2021 | -96.55% |
| Watch | Richard Evans | Premium Only | 2021-06-02 08:25:00 02/06/2021 | – |